000 | 01914 a2200517 4500 | ||
---|---|---|---|
005 | 20250516130002.0 | ||
264 | 0 | _c20130528 | |
008 | 201305s 0 0 eng d | ||
022 | _a1879-0852 | ||
024 | 7 |
_a10.1016/j.ejca.2012.11.027 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan der Burg, M E L | |
245 | 0 | 0 |
_aLong-term results of weekly paclitaxel carboplatin induction therapy: an effective and well-tolerated treatment in patients with platinum-resistant ovarian cancer. _h[electronic resource] |
260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cApr 2013 |
||
300 |
_a1254-63 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInduction Chemotherapy _xmethods |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNausea _xchemically induced |
650 | 0 | 4 | _aNeoplasm Grading |
650 | 0 | 4 |
_aNeutropenia _xchemically induced |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVomiting _xchemically induced |
700 | 1 | _aVergote, I | |
700 | 1 | _aOnstenk, W | |
700 | 1 | _aBoere, I A | |
700 | 1 | _aLeunen, K | |
700 | 1 | _avan Montfort, C A G M | |
700 | 1 | _avan Doorn, H C | |
773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 49 _gno. 6 _gp. 1254-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2012.11.027 _zAvailable from publisher's website |
999 |
_c22381143 _d22381143 |